We chose a voice-based interface over the more commonly used smartphone interface because of its potential to improve access, usability, and convenience, especially for older patients with diabetes.28,29,30,31 We evaluated the effectiveness of the VBAI in medication adherence, glycemic control, and time to optimal insulin dose compared with standard of care. This evidence concerns the gene INS and diabetes mellitus.